Global access of rifabutin for the treatment of tuberculosis – why should we prioritize this?

INTRODUCTION: Rifabutin, a rifamycin of equivalent potency to rifampicin, has several advantages in its pharmacokinetic and toxicity profile, particularly in HIV co‐infected patients on combined antiretroviral therapy (cART). In this commentary, we evaluate evidence supporting increased global use o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Int AIDS Soc
Main Authors: Rockwood, Neesha, Cerrone, Maddalena, Barber, Melissa, Hill, Andrew M, Pozniak, Anton L
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Commentary
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6637439/
https://ncbi.nlm.nih.gov/pubmed/31318176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jia2.25333
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker